Matt is a partner in Cooley’s emerging companies group. His practice includes venture capital financings, mergers & acquisitions, and general corporate representation of high-growth companies. Matt represents a number of private company clients with a focus on the life sciences, digital health and national security sectors. He also represents leading venture capital firms in their investment activities.
Download full bio